# Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.

> **NCT03062644** · PHASE3 · COMPLETED · sponsor: **Mundipharma Research GmbH & Co KG** · enrollment: 1138 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** MR308
- **DRUG:** MR308
- **DRUG:** MR308
- **DRUG:** MR308

## Key facts

- **NCT ID:** NCT03062644
- **Lead sponsor:** Mundipharma Research GmbH & Co KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2018-06-29
- **Final completion:** 2018-06-29
- **Target enrollment:** 1138 (ACTUAL)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062644, "Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03062644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*